Literature DB >> 19801888

Predictive factors of esophageal stenosis associated with tumor regression in radiation therapy for locally advanced esophageal cancer.

Kazushige Atsumi1, Yoshiyuki Shioyama, Katsumasa Nakamura, Satoshi Nomoto, Saiji Ohga, Tadamasa Yoshitake, Takeshi Nonoshita, Masanobu Ueda, Hideki Hirata, Hiroshi Honda.   

Abstract

The purpose of this retrospective study was to clarify the predictive factors correlated with esophageal stenosis within three months after radiation therapy for locally advanced esophageal cancer. We enrolled 47 patients with advanced esophageal cancer with T2-4 and stage II-III who were treated with definitive radiation therapy and achieving complete response of primary lesion at Kyushu University Hospital between January 1998 and December 2005. Esophagography was performed for all patients before treatment and within three months after completion of the radiation therapy, the esophageal stenotic ratio was evaluated. The stenotic ratio was used to define four levels of stenosis: stenosis level 1, stenotic ratio of 0-25%; 2, 25-50%; 3,50-75%; 4,75-100%. We then estimated the correlation between the esophageal stenosis level after radiation therapy and each of numerous factors. The numbers and total percentages of patients at each stenosis level were as follows: level 1: n = 14 (30%); level 2: 8 (17%); level 3: 14 (30%); and level 4: 11 (23%). Esophageal stenosis in the case of full circumference involvement tended to be more severe and more frequent. Increases in wall thickness tended to be associated with increases in esophageal stenosis severity and frequency. The extent of involved circumference and wall thickness of tumor region were significantly correlated with esophageal stenosis associated with tumor regression in radiation therapy (p = 0.0006, p = 0.005). For predicting the possibility of esophageal stenosis with tumor regression within three months in radiation therapy, the extent of involved circumference and esophageal wall thickness of the tumor region may be useful.

Entities:  

Mesh:

Year:  2009        PMID: 19801888     DOI: 10.1269/jrr.09073

Source DB:  PubMed          Journal:  J Radiat Res        ISSN: 0449-3060            Impact factor:   2.724


  3 in total

Review 1.  Update on the management of the gastrointestinal effects of radiation.

Authors:  Hannah McCaughan; Stephen Boyle; John J McGoran
Journal:  World J Gastrointest Oncol       Date:  2021-05-15

2.  Additional radiotherapy following endoscopic submucosal dissection for T1a-MM/T1b-SM esophageal squamous cell carcinoma improves locoregional control.

Authors:  Osamu Hisano; Takeshi Nonoshita; Hidenari Hirata; Tomonari Sasaki; Hideyuki Watanabe; Hiroaki Wakiyama; Minoru Ono; Saiji Ohga; Hiroshi Honda
Journal:  Radiat Oncol       Date:  2018-01-29       Impact factor: 3.481

3.  UK guidelines on oesophageal dilatation in clinical practice.

Authors:  Sarmed S Sami; Hasan N Haboubi; Yeng Ang; Philip Boger; Pradeep Bhandari; John de Caestecker; Helen Griffiths; Rehan Haidry; Hans-Ulrich Laasch; Praful Patel; Stuart Paterson; Krish Ragunath; Peter Watson; Peter D Siersema; Stephen E Attwood
Journal:  Gut       Date:  2018-02-24       Impact factor: 23.059

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.